Parkinson's is, IMO, what will take this stock to levels we never dreamed of and be of incredible benefit to those afflicted. Win/Win. It will take a while but Opicapone as an adjunctive treatment in the short term transitioning to VY-AADC in the long term seems logical. Who knows what the other two compounds that Neurocrine has to select from the Voyager chest will bring. Neurocrine is becoming the leader in movement disorders and it is a lucrative and medically beneficial path. I wish I was younger, but then again there is no cure for that.